Protein-bound polysaccharide K induced apoptosis of the human Burkitt lymphoma cell line, Namalwa

Biomedicine and Pharmacotherapy

Volumn 58, Issue 4, 2004, Pages 226-230

  Hattori, Takako Saisho ^a   Komatsu, Nobukazu ^a   Shichijo, Shigeki ^a   Itoh, Kyogo ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; biological response modifier; BRM; Galactose; protein bound polysaccharide K; Protein bound polysaccharide K (PSK); PSK

Indexed keywords

GALACTOSE; KRESTIN; PROTEIN BOUND POLYSACCHARIDE K; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BURKITT LYMPHOMA; CELL GROWTH; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; MUSHROOM; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BETA-GALACTOSIDASE; BURKITT LYMPHOMA; CELL LINE, TUMOR; CELL SURVIVAL; GALACTOSE; HUMANS; PROTEOGLYCANS;

EID: 2942566695     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2004.02.004     Document Type: Article

References (29)

1. Fisher M., Yang L.X. Anticancer effects and mechanisms of polysaccharide K (PSK): implications of cancer immunotherapy. Anticancer Res. 22:2002;1737
2. Kidd P.M. The use of mushroom glucans and proteoglycans in cancer treatment. Altern Med Rev. 5:2000;4
3. Kobayashi H., Matsunaga K., Oguchi Y. Antimetastatic effects of PSK (Krestin), a protein-bound polysaccharide obtained from basidiomycetes: an overview. Cancer Epidemiol Biomarkers Prev. 4:1995;275
4. Tsukagoshi S., Hashimoto Y., Fujii G., Kobayashi H., Nomoto K., Orita K. Krestin (PSK). Cancer Treat Rev. 11:1984;131
5. Wasser S.P. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol. 60:2002;258
6. Ooi V.E., Liu F. Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem. 7:2000;715
7. Branicki F.J., Chu K.M. Gastric cancer in Asia: progress and controversies in surgical management. Aust New Zealand J Surg. 68:1998;172
8. Fukushima M. Adjuvant therapy of gastric cancer: the Japanese experience. Semin Oncol. 23:1996;369
9. Hayakawa K., Mitsuhashi N., Saito Y., Nakayama Y., Furuta M., Nakamoto S., et al. Effect of Krestin as adjuvant treatment following radical radiotherapy in non-small cell lung cancer patients. Cancer Detect Prev. 21:1997;71
10. Kudo S., Tanaka J., Kashida H., Tamegai Y., Endo S., Yamano H.O. Effectiveness of immunochemotherapy with PSK, a protein-bound polysaccharide, in colorectal cancer and changes of tumor marker. Oncol Rep. 9:2002;635
11. Nio Y., Tsubono M., Tseng C.C., Morimoto H., Kawabata K., Masai Y., et al. Immunomodulation by orally administered protein-bound polysaccharide PSK in patients with gastrointestinal cancer. Biotherapy. 4:1992;117
12. Ogoshi K., Satou H., Isono K., Mitomi T., Endoh M., Sugita M. Immunotherapy for esophageal cancer. A randomized trial in combination with radiotherapy and radiochemotherapy. Am J Clin Oncol. 18:1995;216. Cooperative Study Group for Esophageal Cancer in Japan
13. Torisu M., Hayashi Y., Ishimitsu T., Fujimura T., Iwasaki K., Katano M., et al. Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer. Cancer Immunol Immunother. 31:1990;261
14. Algarra I., Collado A., Garcia Lora A., Garrido F. Differential effect of protein-bound polysaccharide (PSK) on survival of experimental murine tumors. J Exp Clin Cancer Res. 18:1999;39
15. Matsunaga K., Ohhara M., Oguchi Y., Iijima H., Kobayashi H. Antimetastatic effect of PSK, a protein-bound polysaccharide, against the B16-BL6 mouse melanoma. Invasion Metastasis. 16:1996;27
16. Kawa K., Konishi S., Tsujino G., Mabuchi S. Effects of biological response modifiers on childhood ALL being in remission after chemotherapy. Biomed Pharmacother. 45:1991;113
17. Ohno R., Yamada K., Masaoka T., Ohshima T., Amaki I., Hirota Y., et al. A randomized trial of chemoimmunotherapy of acute nonlymphocytic leukemia in adults using a protein-bound polysaccharide preparation. Cancer Immunol Immunother. 18:1984;149
18. Yefenof E., Gafanovitch I., Oron E., Bar M., Klein E. Prophylactic intervention in radiation-leukemia-virus-induced murine lymphoma by the biological response modifier polysaccharide K. Cancer Immunol Immunother. 41:1995;389
19. Jackson A., Warner N. Preparation, staining and analysis by flow cytometry of peripheral blood leukocytes. 3rd ed Manual of clinical immunology. 1986;226 American Society for Microbiology, Washington (DC)
20. Vermes I., Haanen C., Steffens Nakken H., Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods. 184:1995;39
21. Pedrinaci S., Algarra I., Garrido F. Protein-bound polysaccharide (PSK) induces cytotoxic activity in the NKL human natural killer cell line. Int J Clin Lab Res. 29:1999;135
22. Garcia Lora A., Pedrinaci S., Garrido F. Protein-bound polysaccharide K and interleukin-2 regulate different nuclear transcription factors in the NKL human natural killer cell line. Cancer Immunol Immunother. 50:2001;191
23. Ebina T., Murata K. Antitumor effect of PSK at a distant site: tumor-specific immunity and combination with other chemotherapeutic agents. Jpn J Cancer Res. 83:1990;775
24. Iguchi C., Nio Y., Takeda H., Yamasawa K., Hirahara N., Toga T., et al. Plant polysaccharide PSK: cytostatic effects on growth and invasion; modulating effect on the expression of HLA and adhesion molecules on human gastric and colonic tumor cell surface. Anticancer Res. 21:2001;1007
25. Katano M., Yamamoto H., Torisu M. A suppressive effect of PSK, a protein-bound polysaccharide preparation, on tumor growth: a new effect of PSK on cell motility. Gan To Kagaku Ryoho. 14:1987;2321
26. Hebert E. Endogenous lectins as cell surface transducers. Biosci Rep. 20:2000;213-237
27. Danguy A., Camby I., Kiss R. Galectins and cancer. Biochim Biophys Acta. 1572:2002;285
28. Kilpatrick D.C. Animal lectins: a historical introduction and overview. Biochim Biophys Acta. 1572:2002;187
29. Rabinovich G.A., Baum L.G., Tinari N., Paganelli R., Natoli C., Liu F.T., et al. Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? Trends Immunol. 23:2002;313